Neuronal nicotinic acetylcholine receptor binding affinities of boron-containing nicotine analogues

Rui Xu, Linda P. Dwoskin, Vladimir P. Grinevich, Gabriela Deaciuc, Peter A. Crooks

Research output: Contribution to journalArticlepeer-review

27 Scopus citations

Abstract

A series of boron-containing nicotine (NIC) analogues 7-9 was synthesized and evaluated for binding to α4β2 and α7 nicotinic receptors. Compound ACME-B inhibited [3H]methyllycaconitine binding to rat brain membranes with a similar potency compared to NIC (Ki=2.4 and 0.77 μM, respectively), but was markedly less potent in inhibiting [3H]NIC binding when compared to NIC (Ki=0.60 μM and 1.0 nM, respectively). Thus, tethering a two-carbon bridge between the 2-pyridyl and 3′-pyrrolidino carbons of NIC or 7 affords analogues that bind to the α7 receptor in a manner similar to NIC, but with a dramatic loss of affinity for the α4β2 receptor.

Original languageEnglish
Pages (from-to)1245-1248
Number of pages4
JournalBioorganic and Medicinal Chemistry Letters
Volume11
Issue number9
DOIs
StatePublished - May 7 2001

Bibliographical note

Funding Information:
This work was supported by grants from the National Institute on Drug Abuse (DA10394 and DA00399) and Layton Bioscience, Inc.

Funding

This work was supported by grants from the National Institute on Drug Abuse (DA10394 and DA00399) and Layton Bioscience, Inc.

FundersFunder number
Layton Bioscience, Inc.
National Institute on Drug AbuseR43DA010394, DA00399

    ASJC Scopus subject areas

    • Biochemistry
    • Molecular Medicine
    • Molecular Biology
    • Pharmaceutical Science
    • Drug Discovery
    • Clinical Biochemistry
    • Organic Chemistry

    Fingerprint

    Dive into the research topics of 'Neuronal nicotinic acetylcholine receptor binding affinities of boron-containing nicotine analogues'. Together they form a unique fingerprint.

    Cite this